ROYAL BANK OF CANADA - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 11 filers reported holding NOVABAY PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$05000.0%0.00%
Q2 2022$0
-100.0%
500
-83.3%
0.00%
Q2 2020$3,0003,000
+37400.0%
0.00%
Q4 2019$08
+14.3%
0.00%
Q3 2019$07
-30.0%
0.00%
Q2 2019$010
-16.7%
0.00%
Q1 2019$0120.0%0.00%
Q4 2018$0120.0%0.00%
Q3 2018$012
+200.0%
0.00%
Q2 2018$040.0%0.00%
Q1 2018$04
-63.6%
0.00%
Q4 2017$0110.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Virtu Financial LLC 46,903$34,0000.01%
TOWNSQUARE CAPITAL LLC 53,672$40,0000.00%
NVWM, LLC 2,997$2,0000.00%
VANGUARD GROUP INC 152,309$111,0000.00%
UBS Group AG 2,000$1,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 25,000$18,0000.00%
Sugarloaf Wealth Management, LLC 2,000$1,0000.00%
OSAIC HOLDINGS, INC. 5,260$4,0000.00%
BANK OF AMERICA CORP /DE/ 3,000$2,0000.00%
WELLS FARGO & COMPANY/MN 7,514$5,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders